Opus Genetics, Inc. (Nasdaq: IRD) (the "Company” or "Opus Genetics”) a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and ...
Figures on CO? equivalents and emissions collected and published by companies and institutions today often rely on rough estimates, averages and systemically questionable industry standards. Access to ...
Survivors of the Eaton and Palisades fires are calling on Gov. Gavin Newsom to urge California Insurance Commissioner Ricardo ...
A 2017 California law is meant to protect the rights of gay and transgender people in nursing homes, including by forbidding ...
Third Quarter Total Revenue of $86.0 Million, an Increase of 3% Versus Prior Year. Total ARR of $355.7 Million, an Increase of 2% Versus Prior Year. Enterprise ARR of $269.2 Million, an Increase of 5% ...
The latest national report of the American Lung Association 2025: State of Lung Cancer Report was published on Nov 5, 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback